Skip to main content
Log in

The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study was to comparatively evaluate oxidative status of ankylosing spondylitis (AS) patients receiving anti-tumor necrosis factor (TNF) or non-steroid anti-inflammatory drugs (NSAID). Forty-seven patients with AS and 27 healthy controls were enrolled. Of these, 23 were on anti-TNF (group 1) and 24 on NSAIDs (group 2). Groups 1 and 2 were consisted of matched patients with respect to age, gender, body mass index, disease duration, C-reactive protein, erythrocyte sedimentation rate, total cholesterol, and Bath Ankylosing Spondylitis Disease Activity Index. Mean duration of treatment for patients in group 1 was 12.6 ± 6.8 months. Serum total antioxidative status (TAS) and total oxidative status (TOS) levels were determined using new automated methods. Oxidative stress index (OSI) was calculated. The groups' carotid intima-media thicknesses (IMT-C) were also measured using ultrasonography. Group 1 had the highest TAS and lowest TOS levels. The TOS levels of group 1 was lower than the control, while group 2 being higher than controls. The difference in TOS levels between group 1 and group 2 was statistically significant (p = 0.040). OSI values were highest in group 2 and lowest in group 1. There was no significant correlation between oxidant/antioxidant parameters and IMT-C for group 1 (r = −0.30, p = 0.198 for OSI; r = 0.22, p = 0.366 for TAS; r = −0.22, p = 0.361 for TOS). This is the first study to evaluate total oxidative/antioxidative status in patients with AS on anti-TNF agent. These results clearly indicate positive effects of anti-TNF treatment on oxidative status of AS patients. The limited effects of NSAIDs compared with controls may be due to excess impaired oxidative status in the patients in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arnett FC (2001) Ankylosing spondylitis. In: Koopman WJ (ed) Arthritis and allied conditions. Philadelphia: Lippincott Williams and Wilkins, pp 1311–1323

  2. Sarban S, Kocyigit A, Yazar M, Isikan UE (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38(11):981–986

    Article  CAS  PubMed  Google Scholar 

  3. Stichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Frölich JC (1995) Elevated serum nitrate concentrations in active spondyloarthropathies. Br J Rheumatol 34(7):616–619

    Article  CAS  PubMed  Google Scholar 

  4. Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24:80–83

    Article  CAS  PubMed  Google Scholar 

  5. Yazici C, Köse K, Calis M, Kuzugüden S, Kirnap M (2004) Protein oxidation status in patients with ankylosing spondylitis. Rheumatology (Oxford) 43(10):1235–1239

    Article  CAS  Google Scholar 

  6. Cunnane G, Bresnihan B, FitzGerald O (1998) Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis. Arthritis Rheum 41:180–182

    Article  CAS  PubMed  Google Scholar 

  7. Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M et al (2003) International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. ASAS working group. Ann Rheum Dis 62(9):817–824

    Article  CAS  PubMed  Google Scholar 

  8. Sari I, Okan T, Akar S, Cece H, Altay C, Secil M et al (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 45(3):283–286

    Article  CAS  Google Scholar 

  9. Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    Article  PubMed  Google Scholar 

  10. Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Daugados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 38:878–882

    Article  CAS  PubMed  Google Scholar 

  11. Rabus M, Demirbağ R, Sezen Y, Konukoğlu O, Yildiz A, Erel O et al (2008) Plasma and tissue oxidative stress index in patients with rheumatic and degenerative heart valve disease. Turk Kardiyol Dern Ars 36(8):536–540

    PubMed  Google Scholar 

  12. Tak PP, Zvaifler NJ, Green DR, Firestein GS (2000) Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 21(2):78–82

    Article  CAS  PubMed  Google Scholar 

  13. Wendling D, Didier JM, Vuitton DA (1991) The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int 11(4–5):187–189

    Article  CAS  PubMed  Google Scholar 

  14. Mitrofanova OV, Bagirova VV, Krasikov SI (2002) Levels of lipid peroxidation products and activity of antiradical defense enzymes in blood of patients with Bechterew disease. Ter Arkh 74(5):66–69

    CAS  PubMed  Google Scholar 

  15. Karakoc M, Altindag O, Keles H, Soran N, Selek S (2007) Serum oxidative-antioxidative status in patients with ankylosing spondylitis. Rheumatol Int 27(12):1131–1134

    Article  CAS  PubMed  Google Scholar 

  16. Braun J, Baraliakos X, Listing J, Sieper J (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52(8):2447–2451

    Article  CAS  PubMed  Google Scholar 

  17. Pay S, Musabak U, Erdem H, Simsek I, Pekel A, Sengul A et al (2005) Chimerical anti-TNF-alpha, infliximab, inhibits neutrophil chemotaxis and production of reactive oxygen species by blocking the priming effect of mononuclear cells on neutrophils. Immunopharmacol Immunotoxicol 27(2):187–198

    Article  CAS  PubMed  Google Scholar 

  18. den Broeder AA, Wanten GJ, Oyen WJ, Naber T, van Riel PL, Barrera P (2003) Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis. J Rheumatol 30(2):232–237

    Google Scholar 

  19. Prónai L, Ichikawa Y, Ichimori K, Nakazawa H, Arimori S (1991) Association of enhanced superoxide generation by neutrophils with low superoxide scavenging activity of the peripheral blood, joint fluid, and their leukocyte components in rheumatoid arthritis: effects of slow-acting anti-rheumatic drugs and disease activity. Clin Exp Rheumatol 9:149–155

    PubMed  Google Scholar 

  20. Pullar T, Zoma A, Capell HA, Khan MF, Brown DH, Smith WE (1987) Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol 26(3):202–206

    Article  CAS  PubMed  Google Scholar 

  21. Nordmann R (1994) Alcohol and antioxidant systems. Alcohol 29(5):513–522

    CAS  Google Scholar 

  22. Brown KM, Morrice PC, Arthur JR, Duthie GG (1996) Effects of vitamin E supplementation on erythrocyte antioxidant defence mechanisms of smoking and non-smoking men. Clin Sci 91(1):107–111

    CAS  PubMed  Google Scholar 

  23. Toth KM, Berger EM, Beehler CJ, Repine JE (1986) Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers. Am Rev Respir Dis 134(2):281–284

    CAS  PubMed  Google Scholar 

  24. Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82(2):291–295

    CAS  PubMed  Google Scholar 

  25. Lekakis JP, Papamichael CM, Cimponeriu AT, Stamatelopoulos KS, Papaioannou TG, Kanakakis J et al (2000) Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis. Am J Cardiol 85(8):949–952

    Article  CAS  PubMed  Google Scholar 

  26. Delles C, Zimmerli LU, McGrane DJ, Koh-Tan CH, Pathi VL, McKay AJ (2008) Vascular stiffness is related to superoxide generation in the vessel wall. J Hypertens 26(5):946–955

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Murat Karkucak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karkucak, M., Capkin, E., Alver, A. et al. The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis. Clin Rheumatol 29, 303–307 (2010). https://doi.org/10.1007/s10067-009-1325-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-009-1325-6

Keywords

Navigation